Xencor reported $54.28M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US $ 142.27M 14.26M
Amgen AMGN:US $ 5327M 250M
Arrowhead Research ARWR:US $ 0.24M 1.08M
AstraZeneca AZN:LN 9.61B 562M
Biogen BIIB:US $ 2003.5M 17.9M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Cytokinetics CYTK:US $ 1.97M 4.08M
Epizyme EPZM:US $ 5.9M 670K
GlaxoSmithKline GSK:LN 6.87B 1.93B
Karyopharm Therapeutics KPTI:US $ 23.48M 1.51M
Macrogenics MGNX:US $ 18.38M 3.48M
Novartis NOVN:VX 8.91B 232M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Seattle Genetics SGEN:US $ 438.04M 37.03M
Xencor XNCR:US $ 54.28M 38.92M